Advancing dentin-pulp regeneration: clinical perspectives and insights from stem/progenitor cell transplantation (part II)

被引:0
|
作者
Shamszadeh, Sayna [1 ]
Eghbal, Mohammad Jafar [1 ]
Asgary, Saeed [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Res Inst Dent Sci, Iranian Ctr Endodont Res, Tehran, Iran
来源
AMERICAN JOURNAL OF STEM CELLS | 2024年 / 13卷 / 03期
关键词
Dentin-pulp complex; dental pulp stem cells; regenerative endodontics; stem cell transplantation; systematic review; MESENCHYMAL STEM-CELLS; APICAL PERIODONTITIS; STROMAL CELLS; DIFFERENTIATION; DELIVERY; TISSUE; TESTS; TEETH; TOOTH;
D O I
10.62347/BYPG4014
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This systematic review evaluates clinical studies investigating regenerative endodontic procedures for mature/immature teeth utilizing stem cell transplantation. An electronic search of Scopus, PubMed, ISI Web Science, and Google Scholar was conducted up to January 2023. Outcome measures encompassed radiographic (periapical lesion, root length, apical foramen width, volume of the regenerated pulp) and clinical (post-operative pain, sensibility test) parameters. Among 3250 identified articles, five clinical studies were selected, comprising two randomized controlled trials (RCTs) for mature/immature teeth, and three case reports/series for mature teeth. Despite the promising potential, the included studies exhibited a notable risk of bias. The diversity in stem cells (e.g., dental pulp stem cells [DPSCs], umbilical cord mesenchymal stem cells [UC-MSCs]), scaffolds (Atecollagen, collagen membrane, platelet-poor plasma [PPP], leukocyte platelet-rich in fibrin [L-PRF]), and growth factors (granulocyte colony-stimulating factor [G-CSF]) emphasized the heterogeneity across interventions. In RCTs, DPSCs application increased root length and reduced apical foramen width in immature teeth, while UC-MSCs transplantation reduced apical lesions in mature teeth. Transplantation of DPSCs aggregates or UC-MSCs/PPP also elicited positive pulp responses and increased blood flow. In case reports/series, DPSCs application in teeth with irreversible pulpitis resulted in mineralization and increased the regenerated pulp' volume. Furthermore, transplantation of DPSCs with G-CSF/atelocollagen or L-PRF/collagen membrane led to positive pulp responses. While underscoring the potential of stem cell transplantation for regenerative endodontics in mature/immature teeth, the overall evidence quality and the limited number of available studies emphasize the need for cautious interpretation of results. Future welldesigned clinical studies are essential to validate these findings further.
引用
收藏
页码:132 / 142
页数:11
相关论文
共 34 条
  • [21] Pre-clinical study of human umbilical cord mesenchymal stem cell transplantation for the treatment of traumatic brain injury: safety evaluation from immunogenic and oncogenic perspectives
    Wang, Gang
    Wu, Hua-Ling
    Liu, Yue-Ping
    Yan, De-Qi
    Yuan, Zi-Lin
    Chen, Li
    Yang, Qian
    Gao, Yu-Song
    Diao, Bo
    NEURAL REGENERATION RESEARCH, 2022, 17 (02) : 354 - 361
  • [22] Pre-clinical study of human umbilical cord mesenchymal stem cell transplantation for the treatment of traumatic brain injury: safety evaluation from immunogenic and oncogenic perspectives
    Gang Wang
    Hua-Ling Wu
    Yue-Ping Liu
    De-Qi Yan
    Zi-Lin Yuan
    Li Chen
    Qian Yang
    Yu-Song Gao
    Bo Diao
    NeuralRegenerationResearch, 2022, 17 (02) : 354 - 361
  • [23] PHASE I/II STUDY OF PANOBINOSTAT FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH RISK MDS OR AML: INITIAL RESULTS FROM THE PHASE I PART OF THE PANOBEST TRIAL
    Bug, G.
    Burchert, A.
    Kroeger, N.
    Duenzinger, U.
    Wolf, A.
    Huenecke, S.
    Bader, P.
    Serve, H.
    Ottmann, O.
    HAEMATOLOGICA, 2013, 98 : 370 - 370
  • [24] Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part II. Autologous Transplantation-Novel Agents and Immunomodulatory Strategies
    Avigan, David
    Hari, Parameswaran
    Battiwalla, Minoo
    Bishop, Michael R.
    Giralt, Sergio A.
    Hardy, Nancy M.
    Kroeger, Nicolaus
    Wayne, Alan S.
    Hsu, Katharine C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (12) : 1661 - 1669
  • [25] First Results of a Prospective I/II Clinical Trial in Adult Patients Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors
    De Witte, Moniek
    Van Rhenen, Anna
    Van Sluis, Geerte
    Admiraal, Rick
    van der Wagen, Lotte
    Petersen, Eefke J.
    Raymakers, Reinier
    Minnema, Monique C.
    Janssen, Anke
    Westinga, Kasper
    Halkes, Constantijn J. M.
    Falkenburg, J. H. Frederik
    Boelens, Jaap Jan
    Kuball, Jurgen
    BLOOD, 2018, 132
  • [26] NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse Following Allogeneic Stem Cell Transplantation. Part II: Chronic Leukemias, Myeloproliferative Neoplasms, and Lymphoid Malignancies
    Kroeger, Nicolaus
    Bacher, Ulrike
    Bader, Peter
    Boettcher, Sebastian
    Borowitz, Michael J.
    Dreger, Peter
    Khouri, Issa
    Olavarria, Eduardo
    Radich, Jerald
    Stock, Wendy
    Vose, Julie M.
    Weisdorf, Daniel
    Willasch, Andre
    Giralt, Sergio
    Bishop, Michael R.
    Wayne, Alan S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (10) : 1325 - 1346
  • [27] IMPACT OF GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) ON CLINICAL OUTCOMES IN ALLOGENEIC STEM CELL TRANSPLANTATION: INSIGHTS FROM A SINGLE-CENTER EXPERIENCE AT PRINCESS MARGARET CANCER CENTRE
    Alnughmush, Ahmed
    Sayyed, Ayman
    Kawari, Mohammed
    Remberger, Mats
    Chen, Carol
    Chiarello, Caden
    Pasic, Ivan
    Novitzky-Basso, Igor
    Law, Arjun Datt
    Lam, Wilson
    Kim, Dennis
    Michelis, Fotios V.
    Gerbitz, Armin
    Viswabandya, Auro
    Kumar, Rajat
    Mattsson, Jonas
    BONE MARROW TRANSPLANTATION, 2024, 59 : 558 - 559
  • [28] In vivo T-cell depletion with antithymocyte globulin or alemtuzumab for unrelated donor stem cell transplantation with reduced intensity conditioning: results of a multicentre randomized phase II clinical trial (the Global study) from the GITMO
    Algarotti, A.
    Mico, C.
    Corradini, P.
    Falda, M.
    Alessandrino, E. P.
    Fanin, R.
    Tagliaferri, E.
    Castagna, L.
    Mordini, N.
    Sica, S.
    Santarone, S.
    Levis, A.
    Iori, A.
    Pollichieni, S.
    Sacchi, N.
    Scarano, M.
    Masciulli, A.
    Marchioli, R.
    Bacigalupo, A.
    Bosi, A.
    Rambaldi, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S60 - S61
  • [29] Clinical Response to Azacytidine (AZA) Is Associated with Increased Contribution from Mutated Blood Progenitors: Insights from Single Cell Genotyping of Matched Stem/Progenitor and Mature Blood Cells from MDS/CMML Patients Pre- and Post-AZA Treatment
    Thoms, Julie A., I
    Schnegg-Kaufmann, Annatina
    Bhuyan, Golam Sarower
    Hampton, Henry R.
    Vaughan, Lachlin
    Rutherford, Kayleigh
    Kakadia, Purvi M.
    Lee, Hui Mei
    Johansson, Emma
    Failes, Tim W.
    Arndt, Greg M.
    Koval, Jason
    Davidson, Sarah
    Lindeman, Robert
    Warburton, Pauline
    Rodriguez-Meira, Alba
    Mead, Adam J.
    Unnikrishnan, Ashwin
    Hertzberg, Mark
    Polizzotto, Mark N.
    Papaemmanuil, Elli
    Bohlander, Stefan K.
    Faridani, Omid
    Jolly, Christopher J.
    Zanini, Fabio
    Pimanda, John E.
    BLOOD, 2022, 140 : 9751 - 9752
  • [30] Two Year Analysis of a Prospective Phase I/II Clinical Trial in Adults Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors.
    de Witte, Moniek A.
    Janssen, Anke
    Nijssen, Clara A.
    van Rhenen, Anna
    Admiraal, Rick
    van der Wagen, Lotte
    Minnema, Monique C.
    Petersen, Eefke
    Raymakers, Reinier A. P.
    Westinga, Kasper
    Halkes, Constantijn J. M.
    Boelens, Jaap Jan
    Kuball, Jurgen
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 169 - 170